
Parameswaran Nair, professor of medicine at McMaster and staff respirologist at St. Joseph’s Healthcare Hamilton
Researchers from McMaster University and the Firestone Institute for Respiratory Health at St. Joseph’s Healthcare Hamilton, together with colleagues at other partnering institutions, have developed a new method to treat severe asthma.
In a study of over 200 participants with severe asthma, the new treatment was shown to have improved asthma symptoms and lung function, while reducing the need for corticosteroids by up to 70%.
According to Statistics Canada, eight per cent of Canadians aged 12 or older – approximately 2.4 million people – have been diagnosed with asthma. Of that, approximately 25% are considered to be severe cases of asthma.
Current treatments for severe asthma often include high doses of corticosteroids, such as prednisone, to control exacerbations. Reducing the need for corticosteroids with alternative treatments is preferable, since these medications are associated with serious side effects from prolonged use – including multi-organ toxicities and immunosuppression.
Parameswaran Nair, professor of medicine at McMaster and staff respirologist at St. Joseph’s Healthcare Hamilton, along with a team of researchers found that an antibody called dupilumab is effective in treating severe asthma in place of high doses of prednisone.
The results were published in the New England Journal of Medicine, one of the world’s most influential medical publications.
Researchers sought participants who had been using oral corticosteroids (prednisone) to treat severe asthma for at least six months prior to the study. In addition to their standard regimen of corticosteroids, patients received either dupilumab or a placebo during the 24 week trial. The corticosteroid dose was gradually reduced during weeks four to 20, and maintained at a low level for the final four weeks.
“The ability of dupilumab to increase lung function as markedly as it did in this study, even in the face of [corticosteroid] withdrawal, indicates that it appears to be inhibiting key drivers of lung inflammation,” the researchers noted.
Dupilumab works to treat asthma by blocking two specific proteins (called interleukin-4 and interleukin-13) that are associated with inflammation of the airways.
This technique was based on Nair’s previous research, (published in the New England Journal of Medicine in 2009 and in 2017). Those studies found that blocking another protein, interleukin-5, allowed patients with high eosinophil levels in their blood and airways to reduce their corticosteroid dose. Eosinophils are a type of white blood cell involved with the production of interleukins. High eosinophil levels are directly linked to an increased risk of severe asthma.
Unlike the previous studies, dupilumab was shown to be effective regardless of patients’ eosinophil levels. Despite the reduced prednisone dose, patients in this study not only experienced a decrease in asthma exacerbations, but their lung function also improved significantly.
“Ultimately, our goal is to find new treatment pathways that allow us to circumvent the use of corticosteroids,” said Nair.
“Since dupilumab showed a significant improvement on asthma control regardless of eosinophil levels, we may be able to use this treatment for a wider range of patients than we previously thought possible. This might be due to the broad effects on inflammation in asthma of the two proteins that we were able to block with dupilumab. The treatment was not associated with any serious side effects.”
Learn more: Study Demonstrates New Treatment for Severe Asthma
The Latest on: Asthma
via Google News
The Latest on: Asthma
- Regeneron Announces Positive Phase 2 Data Evaluating Fel d 1 Antibody Cocktail in Cat-allergic Patients with Mild Asthmaon February 27, 2021 at 10:26 pm
Single administration of novel antibody cocktail controlled patients' allergic response to cat allergen, preventing early asthma reactions for the duration of the 3-month trial Patients experienced ...
- Masks Don't Affect Oxygen Saturation in People With Asthmaon February 27, 2021 at 2:08 pm
People with asthma sometimes worry that wearing a mask against COVID-19 won't let them breathe. But a new study demonstrates masks don't affect oxygen saturation.
- Diverse patient population helps identify gene variant associated with childhood asthmaon February 26, 2021 at 11:50 pm
Researchers at Henry Ford Health System, as part of a national asthma collaborative, have identified a gene variant associated with childhood asthma that underscores the importance of including ...
- Tezepelumab Is the First Biologic to Consistently and Significantly Reduce Exacerbations in Broad Population of Severe Asthma Patientson February 26, 2021 at 9:32 pm
Positive full results from the pivotal NAVIGATOR Phase III trial showed AstraZeneca and Amgen’s tezepelumab demonstrated a statistically significant and clinically meaningful 1 reduction in the ...
- New hope for people with severe asthma as trial finds new drug reduces attacks by more than halfon February 26, 2021 at 11:12 am
People with severe asthma have been given hope of a highly effective new treatment after a major trial of a new drug found it reduced asthma attacks by 56 per cent. This was the final stage of the ...
- Diversity among study participants credited with identifying gene linked to asthmaon February 26, 2021 at 8:26 am
Researchers at Henry Ford Health System, as part of a national asthma collaborative, have identified a gene variant associated with childhood asthma that underscores the importance of including ...
- AstraZeneca-Amgen drug could widen treatment options for severe asthmaon February 26, 2021 at 6:11 am
AstraZeneca and Amgen's experimental drug reduced asthma attacks in patients with severe and uncontrolled forms of the respiratory condition in a large study, showing promise for wider use against ...
- College Football Star Justin Foster Forced to Retire Due to COVID Complications and Asthmaon February 24, 2021 at 10:39 pm
"With sadness but no regret, I have decided it is in my best interest to call it a career and hang up football," the Clemson Tigers defensive end wrote in a statement posted to Twitter ...
- Studies Show That Asthma Does Not Increase Risk Of Severe Covid-19 Illnesson February 24, 2021 at 10:40 am
Patients with a history of lung disease, especially asthma, have been considered to be at much higher risk of respiratory complications due to Covid-19, as having asthma leads to chronic as well as ...
via Bing News